The ACT EU programme will map existing clinical trial activities and develop a governance rationalisation strategy.
This aims to clarify the roles and responsibilities of the various expert groups working within the European medicines regulatory network.
The Clinical Trials Regulation (CTR) Collaborate project is initiated by the Clinical Trials Coordination Group (CTCG). Ethics committees and national competent authorities are optimising their collaboration regarding clinical trials authorisation under the CTR. Anchoring the initiative to ACT EU will enable prioritisation of related activities under the programme.
